COMMUNIQUÉS West-GlobeNewswire

Soleno Therapeutics Announces Regulatory Update on DCCR (diazoxide choline) Extended-Release Tablets to Treat Prader-Willi Syndrome

08/10/2024 - 14:30

REDWOOD CITY, Calif., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, [...]

Oncocyte’s DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial

08/10/2024 - 14:30

Results published in peer-reviewed journal , Clinical Cancer Research Study validates DetermaIO’s utility in identifying breast cancer patients most likely to benefit from atezolizumab DetermaIO targets a multi-billion- [...]

SeaStar Medical Expands NEUTRALIZE-AKI Pivotal Trial Adding Two Premier Military Medical Facilities

08/10/2024 - 14:30

DENVER , Oct. 08, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on [...]

Autonomix Medical, Inc. to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC

08/10/2024 - 14:30

Live webcast fireside chat on Tuesday, October 15 th at 2:30 PM ET THE WOODLANDS, TX, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company [...]

Tonix Pharmaceuticals Announces AI Collaboration with X-Chem to Develop Broad-Spectrum Antivirals

08/10/2024 - 14:30

AI (Artificial Intelligence) and ML (Machine Learning) drug discovery collaboration will accelerate the development of small molecules as orally available host-targeted broad-spectrum medical countermeasures Host- [...]

Oragenics Inc. Successfully Completes Key FDA-Recognized Study for ONP-002

08/10/2024 - 14:45

SARASOTA, Fla., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Oragenics Inc. (NYSE American: OGEN), a company focused on developing new treatments for brain-related health conditions, has completed a key study for their new [...]

Parexel’s Teri Karcher Named to 2024 PharmaVoice 100

08/10/2024 - 14:55

Chief Drug Development Officer and Executive Vice President, Head of Launch Excellence recognized for pioneering leadership in drug development DURHAM, N.C., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s [...]

PharmAla to supply the University of Texas, San Antonio, with novel dosage form of LaNeo™ MDMA

08/10/2024 - 14:55

TORONTO, Oct. 08, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of [...]

T2 Biosystems, Inc. and Prxcision, Inc. Announce Co-Marketing Collaboration for Rapid Direct-From-Blood Diagnostics and AI-Powered Decision Support Platform

08/10/2024 - 15:00

Pioneering a new frontier in antibiotic stewardship to combat the growing threat of antimicrobial resistance LEXINGTON, Mass. and SCHENECTADY, N.Y., Oct. 08, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), [...]

Avalyn CEO Lyn Baranowski Named a PharmaVoice 100 Honoree

08/10/2024 - 15:00

CAMBRIDGE, Mass., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc. , a clinical-stage biopharmaceutical company focused on development of inhaled therapies for the treatment of life-threatening pulmonary diseases, [...]

WeightWatchers Adds Compounded GLP-1, Expanding Accessibility and Affordability of Weight Loss Medications

08/10/2024 - 15:00

The new offering, starting at $129, enhances the Company’s holistic weight management program, which includes behavioral and clinical solutions with support from board-certified clinicians, registered dietitians, and [...]

Doheny Eye Institute Announces Upcoming Presentations at American Academy of Ophthalmology 2024 Annual Meeting

08/10/2024 - 15:00

Doheny ophthalmologists selected to give more than 20 presentations and talks PASADENA, Calif., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Doheny Eye Institute , one of the nation’s leading vision research institutions, [...]

Privia Health to Report Third Quarter 2024 Results on Thursday, November 7

08/10/2024 - 15:00

ARLINGTON, Va., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its third quarter and nine-month periods ended September 30, [...]

Kineta Announces Completion of Enrollment in the Monotherapy Arm of the VISTA-101 Phase 1 Clinical Study in Advanced Solid Tumors

08/10/2024 - 15:00

Kineta has completed enrollment in the monotherapy cohorts of the Phase 1 VISTA-101 clinical trial. The ongoing Phase 1 study is now enrolling patients into cohorts evaluating KVA12123 in combination with Merck’s anti- [...]

Curia Commits to SBTi Net-Zero Standard

08/10/2024 - 15:00

ALBANY, N.Y., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Curia, a leading contract research, development and manufacturing organization, today announced its commitment to set near- and long-term company-wide greenhouse gas (GHG [...]

Toronto Maple Leafs' Mitch Marner, London Health Sciences Foundation, partner to launch $50,000 “Marner Match” for Youth Mental Health

08/10/2024 - 15:00

LONDON, Ontario, Oct. 08, 2024 (GLOBE NEWSWIRE) -- London Health Sciences Foundation (LHSF) is teaming up with Mitch Marner of the Toronto Maple Leafs and the Marner Assist Foundation to make a game-changing difference [...]

E-Star BioTech Set to Initiate Phase 2 Clinical Trial of MANP in Resistant Hypertension With Support of Latest Investment

08/10/2024 - 15:00

NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) -- E-Star BioTech, LLC (“E-Star” or the “Company”), an innovative developer of novel peptides designed to treat cardiovascular, metabolic, and kidney diseases, today announced [...]

Growth.Health Announces Launch of Powerful Data & Analytics Platform

08/10/2024 - 15:02

G1 Platform Proves Unsurpassed Customer and Prospect Insights Via Privacy Preserving Records Linkage and Marketing Operationalization ATLANTA, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Growth.Health today announced the launch [...]

Precipio Expands Bloodhound™ MPN Panel by Adding CALR Mutation Subtyping

08/10/2024 - 16:00

The unique assay enables laboratories to provide clinicians with more informed treatment decisions for their patients NEW HAVEN, Conn., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, [...]